This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Nationale Superieure De Chimie De Rennes, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 148 
1 out of 13 
1 out of 14 
Years Active: 2026
Title: Christophe Brigaudeau: Invention and Patent Profile.
Introduction
Christophe Brigaudeau is an inventor associated with Lampaul-Plouarzel, France. His patent work includes an invention concerning inhibitors of store-operated calcium entry (SOCE) and their potential therapeutic applications.
Latest Patents
Brigaudeau is credited with 1 patent: “SOCE Inhibitors and Therapeutic Uses Thereof.” The invention describes SOCE inhibitors intended for use as therapeutic agents across a range of applications. It also covers pharmaceutical compositions, products, and kits containing these inhibitors, as well as methods for using them to treat various diseases.
Career Highlights
Brigaudeau’s listed organizational affiliations include the French National Institute of Health and Medical Research (INSERM) and the University of Western Brittany (Université de Bretagne Occidentale).
Collaborations
His named collaborators include Jean Pierre Bazureau and Déliko Camille Dago.
Conclusion
Christophe Brigaudeau’s patent profile centers on SOCE inhibitors and their proposed therapeutic uses, reflecting work connected with research institutions in France.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile